• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道疾病中的肝脏异常。

Liver abnormalities in bowel diseases.

机构信息

Norwegian PSC Research Center, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Pb 4950 Nydalen, N-0424 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

出版信息

Best Pract Res Clin Gastroenterol. 2013 Aug;27(4):531-42. doi: 10.1016/j.bpg.2013.06.013.

DOI:10.1016/j.bpg.2013.06.013
PMID:24090940
Abstract

Liver abnormalities are often seen in bowel diseases. Whether these represent aspects of two separate diseases, or if one is causing the other, is not always easy to decide. Extraintestinal manifestations of inflammatory bowel disease (IBD) or coeliac disease are frequently observed. Of these extraintestinal manifestations, hepatic disorders are among the most common. Primary sclerosing cholangitis (PSC) and primary biliary cirrhosis are the most frequent hepatic disorders in IBD and coeliac disease, respectively. Genetic studies have lately elucidated the associations between IBD and PSC, but there is still a long way until we have complete understanding of the molecular aetiology and pathophysiology of these conditions. There is no curative treatment available for PSC, besides liver transplantation. Steatosis and cholelithiasis are also common in IBD, as are signs of hepatic injury due to IBD treatment. Less common liver abnormalities include liver abscesses, hepatic thromboembolic events, granulomatous liver disease and hepatic amyloidosis.

摘要

肝脏异常在肠道疾病中很常见。这些是两种独立疾病的表现,还是一种疾病导致另一种疾病,并不总是容易判断的。炎症性肠病(IBD)或乳糜泻的肠外表现经常观察到。在这些肠外表现中,肝脏疾病是最常见的。原发性硬化性胆管炎(PSC)和原发性胆汁性肝硬化分别是 IBD 和乳糜泻中最常见的肝脏疾病。遗传研究最近阐明了 IBD 和 PSC 之间的关联,但要完全了解这些疾病的分子病因和病理生理学,还有很长的路要走。除了肝移植,PSC 没有有效的治疗方法。脂肪变性和胆石症在 IBD 中也很常见,IBD 治疗引起的肝损伤迹象也是如此。不太常见的肝脏异常包括肝脓肿、肝血栓栓塞事件、肉芽肿性肝病和肝淀粉样变性。

相似文献

1
Liver abnormalities in bowel diseases.肠道疾病中的肝脏异常。
Best Pract Res Clin Gastroenterol. 2013 Aug;27(4):531-42. doi: 10.1016/j.bpg.2013.06.013.
2
Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.炎症性肠病的肝胆表现:肠道、药物与肝脏。
World J Gastroenterol. 2013 Nov 14;19(42):7327-40. doi: 10.3748/wjg.v19.i42.7327.
3
Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.原发性硬化性胆管炎对炎症性肠病中的非酒精性脂肪性肝病具有保护作用。
Hum Pathol. 2017 Nov;69:55-62. doi: 10.1016/j.humpath.2017.09.008. Epub 2017 Sep 29.
4
Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.炎症性肠病中自身免疫性肝炎的临床表现及预后
Dig Dis Sci. 2015 Oct;60(10):2873-80. doi: 10.1007/s10620-015-3699-4. Epub 2015 May 22.
5
Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.炎症性肠病相关的肝胆胰管表现和并发症。
Inflamm Bowel Dis. 2010 Sep;16(9):1598-619. doi: 10.1002/ibd.21219.
6
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.原发性硬化性胆管炎中独特的炎症性肠病表型。
World J Gastroenterol. 2015 Feb 14;21(6):1956-71. doi: 10.3748/wjg.v21.i6.1956.
7
[Recurrence of chronic cholestatic liver diseases following liver transplantation].
Gastroenterol Hepatol. 2000 Feb;23 Suppl 1:77-80.
8
Hepatobiliary associations with inflammatory bowel disease.肝胆疾病与炎症性肠病的关系。
Expert Rev Gastroenterol Hepatol. 2009 Dec;3(6):681-91. doi: 10.1586/egh.09.53.
9
What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?在土耳其患者中,原发性硬化性胆管炎与性别及炎症性肠病之间有何关联?
Hepatogastroenterology. 1998 Nov-Dec;45(24):2064-72.
10
Hepatobiliary disorders and complications of inflammatory bowel disease.肝胆疾病与炎症性肠病的并发症。
J Dig Dis. 2011 Aug;12(4):245-56. doi: 10.1111/j.1751-2980.2011.00511.x.

引用本文的文献

1
Role of Olive Leaf Extract, Mesenchymal Stem Cells or Low Radiation Dose in Alleviating Hepatic Injury in Rats.橄榄叶提取物、间充质干细胞或低辐射剂量在减轻大鼠肝损伤中的作用
Dose Response. 2024 Sep 29;22(3):15593258241289301. doi: 10.1177/15593258241289301. eCollection 2024 Jul-Sep.
2
Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.儿童免疫介导性胆管病:为寻找未来可能的治疗靶点,需要更好地了解其病理生理学。
Front Immunol. 2023 Oct 20;14:1206025. doi: 10.3389/fimmu.2023.1206025. eCollection 2023.
3
Polysaccharides from Garlic Protect against Liver Injury in DSS-Induced Inflammatory Bowel Disease of Mice via Suppressing Pyroptosis and Oxidative Damage.
大蒜多糖通过抑制细胞焦亡和氧化损伤来防治 DSS 诱导的小鼠实验性肠炎。
Oxid Med Cell Longev. 2022 Aug 16;2022:2042163. doi: 10.1155/2022/2042163. eCollection 2022.
4
Analysis of the disease activity of ulcerative colitis with and without concomitant primary sclerosing cholangitis: An investigation using a nationwide database in Japan.伴有和不伴有原发性硬化性胆管炎的溃疡性结肠炎疾病活动度分析:一项利用日本全国性数据库的调查。
JGH Open. 2021 Dec 28;6(1):50-56. doi: 10.1002/jgh3.12693. eCollection 2022 Jan.
5
Liver manifestations and complications in inflammatory bowel disease: A review.炎症性肠病的肝脏表现及并发症:综述
World J Hepatol. 2021 Dec 27;13(12):1956-1967. doi: 10.4254/wjh.v13.i12.1956.
6
Hepatobiliary phenotype of individuals with chronic intestinal disorders.慢性肠道疾病患者的肝胆表型。
Sci Rep. 2021 Oct 7;11(1):19954. doi: 10.1038/s41598-021-98843-7.
7
Mechanism of Ulcerative Colitis-Aggravated Liver Fibrosis: The Activation of Hepatic Stellate Cells and TLR4 Signaling Through Gut-Liver Axis.溃疡性结肠炎加重肝纤维化的机制:通过肠-肝轴激活肝星状细胞和TLR4信号通路
Front Physiol. 2021 Sep 17;12:695019. doi: 10.3389/fphys.2021.695019. eCollection 2021.
8
Novel case of percutaneous access of afferent limb of Roux-en-Y hepaticojejunostomy for biliary decompression and jejunoplasty in a patient with primary sclerosing cholangitis.原发性硬化性胆管炎患者经皮穿刺进入Roux-en-Y肝空肠吻合术输入袢进行胆道减压和空肠成形术的新病例。
Radiol Case Rep. 2020 Oct 20;15(12):2681-2686. doi: 10.1016/j.radcr.2020.09.032. eCollection 2020 Dec.
9
An update on treatment options for primary sclerosing cholangitis.原发性硬化性胆管炎治疗方案的最新进展。
Gastroenterol Hepatol Bed Bench. 2020 Spring;13(2):115-124.
10
Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma.胆汁淤积性肝损伤和胆管癌分子机制的综合综述
J Liver. 2018;7(3). doi: 10.4172/2167-0889.1000231. Epub 2018 Sep 20.